Navigation Links
While Half of Facial Injectable Patients Request A Specific Product, Most Still Remain Unaware of Many Brands
Date:2/11/2013

TORONTO, Feb. 11, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, just under half of all patients who received either a botulinum toxin (BTX) or dermal filler injection had requested a specified brand from their physicians. More than 60 percent of physicians comply with such requests. Nevertheless, most patients remain unaware of many available brands of facial injectables, and are even unclear on the differences between BTX and dermal fillers. Manufacturers of brands that are not top of mind will need to focus on education and awareness to compete successfully.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36768LOGO)

Millennium Research Group has produced two complementary Perception Pulse studies, Patient Insights in Facial Injectables and Physician Insights in Facial Injectables, both new for 2013, which analyze the United States market for facial injectables in detail. The results for the patient study are based on a survey of 210 patients in the US who recently received BTX or dermal filler injections. For the physician study, Millennium Research Group surveyed 272 physicians in the US who perform BTX or dermal filler injections, including plastic surgeons and dermatologists in addition to non-core specialties such as general practitioners, internists, dentists, ophthalmologists and otolaryngologists that increasingly perform such procedures.

"Physicians indicate that price has little impact on their decision to purchase and inject a particular BTX or dermal filler brand," said MRG Senior Analyst Nick Morris . "Doctors continue to be willing to pay premium prices for brands they trust, especially when patients are consistently requesting those products by name."

While physicians are aware of most brands, they are considerably less familiar with some of them, and are thus less likely to use them or talk to patients about them. Achieving higher levels of brand familiarity among both physicians and patients is a major challenge faced by many companies in the facial injectables market.

Millennium Research Group's Perception Pulse reports provide unprecedented insight into the behaviors and preferences of those responsible for the purchase and use of medical devices, particularly illuminating why changes are happening in a particular market. Patient Insights in Facial Injectables and Physician Insights in Facial Injectables are essential tools for companies active in the US facial injectable market and looking to better understand brand perceptions and customer behaviors.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
2. Kick Off Summer Vacation With Five Simple Tips to Safely Store Medicines While Traveling
3. New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards
4. Dallas Car Wreck Lawyer Discusses Serious Consequences of Driving While Under the Influence of Drugs
5. Herborium Group Achieves Major Milestones While Making Significant Progress On All Fronts Of Marketing Its Products
6. Biometrics Limits Abuse while Improving Convenience
7. Brazil Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
8. South and Central America Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
9. Perfect Your Holiday Look this Season with the BMR Facial Toner
10. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
11. Summer Is the Best Time for Injectable Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017 Cognitive Computing for ... is allowing a previously unattainable level of personalized ... this ability, it is anticipated that the Global ... Billion by 2022. The growth of the market ... computing platforms, rising installation of cognitive computing software ...
(Date:2/21/2017)... Feb. 21, 2017  /PR Newswire/ -- UBM Medica,s ... announce the launch of Modern Retina ( ... retina specialists. Built upon the success of ... on the latest innovations in the areas of retinal ... management. By meeting current informational needs and filling existing ...
(Date:2/21/2017)... Scientists From Two Companies to Accelerate Development ... ... STEER, creator of advanced materials platform technologies that effectively ... pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, today announced a ... , a leading science & technology company, on ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... A new ... women are called back for additional examinations without sacrificing cancer detection, according to ... 2011, the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for ...
(Date:2/20/2017)... (PRWEB) , ... February 21, 2017 , ... Nancy ... offering readers a way to “ Getting Over the Bump in the Road ” ... and lessons learned on how to cope with the ups and downs experienced by ...
(Date:2/20/2017)... ... ... Silverado today is pleased to announce that it has entered into a management ... Alexandria, Virginia. The new community is expected to open its doors in the first ... three-story community with underground parking – located on King Street –will serve 66 people ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... 213-8818 , Orbita, Inc., a leading provider of innovative software for connected home ... patient engagement and optimizing care journey management for home healthcare. , Built ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... a cloud-based self-service technology that runs on the Posiflex XT-series of touch screen ... during HIMSS17 in Orlando, Florida. The terminal provider Posiflex is helping ...
Breaking Medicine News(10 mins):